Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Experimental Oncology|July 1, 2020
Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different originH Lamdan, R S Garcia-Lazaro, N Lorenzo, et al.
International Journal of Cancer|May 29, 1997
A phospholipase D and protein kinase C inhibitor blocks the spreading of murine mammary adenocarcinoma cells altering f-actin and beta1-integrin point contact distributionJ A Aguirre Ghiso, E F Farías, D F Alonso, et al.
Anticancer Research|January 19, 1999
Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428D F Alonso, A M Tejera, E F Farias, et al.
Oncology Reports|July 31, 1998
Histopathological findings in a highly invasive mouse mammary carcinoma transfected with human tissue inhibitor of metalloproteinases-1D F Alonso, G Skilton, M S De Lorenzo, et al.
Journal of Surgical Oncology|August 1, 1996
Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinomaD F Alonso, E F Farías, A Urtreger, et al.
European Journal of Biochemistry|July 17, 1999
Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotypeJ A Aguirre Ghiso, D F Alonso, E F Farías, et al.
Breast Cancer Research and Treatment|November 5, 1998
Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesisD F Alonso, H G Farina, G Skilton, et al.
Critical Reviews in Oncology/Hematology|March 18, 2018
Relevance of small GTPase Rac1 pathway in drug and radio-resistance mechanisms: Opportunities in cancer therapeuticsG A Cardama, D F Alonso, N Gonzalez, et al.
Journal of the Neurological Sciences|July 1, 1996
Excessive urokinase-type plasminogen activator activity in the euglobulin fraction of patients with Alzheimer-type dementiaD F Alonso, E F Farias, A L Famulari, et al.
Melanoma Research|July 27, 2001
A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivoA Carr, Z Mazorra, D F Alonso, et al.
Pageof 4